Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3198202

Cc1cccc(C)c1N=C1CCCc2cc3c(nc21)C(=Nc1c(C)cccc1C)CCC3.[Cl-].[Cl-].[Fe+2]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 1/20 0.32
ALOX12 P18054 1/20 0.31
NUDT1 P36639 1/20 0.30
MEN1 O00255 1/20 0.30
HSP90AA1 P07900 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3198438 0.97 MAPT (0.37) MAPTKDM4ELMNAHTTRAB9A
SCHEMBL3198441 0.97 MAPT (0.37) MAPTKDM4ELMNAHTTRAB9A
SCHEMBL13418972 0.97 MAPT (0.37) MAPTKDM4ELMNAHTTRAB9A
Hydrochloric Acid SCHEMBL3208211 0.82 TAAR1 (0.31) KDM4E
SCHEMBL12021102 0.81 RAB9A (0.36) MAPTKDM4ELMNAHTTRAB9A
SCHEMBL3195185 0.81 RAB9A (0.36) MAPTKDM4ELMNAHTTRAB9A
SCHEMBL12020994 0.79 MAPT (0.34) MAPTKDM4EKMT2A
SCHEMBL3209293 0.78 KDM4E (0.32) MAPTKDM4ELMNAHTTRAB9A
SCHEMBL14804878 0.78 KDM4E (0.32) MAPTKDM4ELMNAHTTRAB9A
SCHEMBL3193450 0.75 NPY5R (0.39) MAPTKDM4ELMNAHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683149-B2 Catalysts for olefin polymerization or oligomerization E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-03-23 US disclosed
US-20080287621-A1 Catalysts for olefin polymerization or oligomerization DUPONT POLYMERS, INC. 2008-11-20 US disclosed
US-7442819-B2 Catalysts for olefin polymerization or oligomerization E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-10-28 US disclosed
US-20060009597-A1 Catalysts for olefin polymerization or oligomerization DUPONT POLYMERS, INC. 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060009597-A1 Catalysts for olefin polymerization or oligomerization PPOX, HMOX1, NOD2 MAPT 525/4885KDM4E 3147/4885LMNA 3782/4885
US-20080287621-A1 Catalysts for olefin polymerization or oligomerization PPOX, HMOX1, NOD2 MAPT 525/4885KDM4E 3147/4885LMNA 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.